![Silvia Scherer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Silvia Scherer currently works at Aptissen SA, as Chief Executive Officer from 2023 and TOPADUR Pharma AG, as Director from 2020.
Cargos activos de Silvia Scherer
Empresas | Cargo | Inicio |
---|---|---|
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | Director/Miembro de la Junta | 01/01/2020 |
Aptissen SA
![]() Aptissen SA Medical SpecialtiesHealth Technology Aptissen SA is a Swiss company that focuses on researching, developing, and commercializing medical devices that are based on biopolymers. | Director Ejecutivo | 01/06/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | Health Technology |
Aptissen SA
![]() Aptissen SA Medical SpecialtiesHealth Technology Aptissen SA is a Swiss company that focuses on researching, developing, and commercializing medical devices that are based on biopolymers. | Health Technology |
- Bolsa de valores
- Insiders
- Silvia Scherer